ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

ClinicalTrials.gov ID: NCT05291234

Public ClinicalTrials.gov record NCT05291234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-916 in Subjects With Early Alzheimer's Disease

Study identification

NCT ID
NCT05291234
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
106 participants

Conditions and interventions

Interventions

  • ABBV-916 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 14, 2022
Primary completion
Nov 18, 2025
Completion
Nov 18, 2025
Last update posted
Dec 9, 2025

2022 – 2025

United States locations

U.S. sites
32
U.S. states
9
U.S. cities
26
Facility City State ZIP Site status
Tucson Neuroscience Research /ID# 244957 Tucson Arizona 85710-6152
Irvine Clinical Research /ID# 239469 Irvine California 92614
Artemis Institute for Clinical Research - San Diego /ID# 244508 San Diego California 92103-2204
Pacific Research Network, Inc. /ID# 244083 San Diego California 92103
Syrentis Clinical Research /ID# 239682 Santa Ana California 92705
Aventura Neurological Associates /ID# 243892 Aventura Florida 33180
Charter Research - Lady Lake /ID# 244657 Lady Lake Florida 32162
JEM Research Institute /ID# 239122 Lake Worth Florida 33462-1141
ClinCloud - Maitland /ID# 244507 Maitland Florida 32751
ClinCloud LLC - Viera/Melbourne /ID# 240635 Melbourne Florida 32940-8288
Merritt Island Medical Research /ID# 239495 Merritt Island Florida 32952-3616
Optimus U /ID# 245868 Miami Florida 33125-4013
Finlay Medical Research /ID# 245996 Miami Florida 33126
Allied Biomedical Res Inst Inc /ID# 244823 Miami Florida 33155
Renstar Medical Research /ID# 240153 Ocala Florida 34470
K2 Medical Research - Ocoee /ID# 246849 Ocoee Florida 34761-4547
K2 Medical Research - Orlando - South Orlando Avenue /ID# 243919 Orlando Florida 32751
Charter Research - Winter Park /ID# 244778 Orlando Florida 32803-1839
Headlands Research - Orlando /ID# 239119 Orlando Florida 32819
Neurology Associates Ormond Beach /ID# 245527 Ormond Beach Florida 32174
IMIC Inc. Medical Research /ID# 245900 Palmetto Bay Florida 33157
Alzheimer's Research and Treatment Center - Stuart /ID# 245477 Stuart Florida 34997-5765
Alzheimer's Research and Treatment Center - Wellington /ID# 245201 Wellington Florida 33414
Premiere Research Institute - Palm Beach /ID# 240108 West Palm Beach Florida 33407-3209
Clinical Site Partners (CSP) - Orlando /ID# 245127 Winter Park Florida 32789-4681
Conquest Research /ID# 243916 Winter Park Florida 32789
Columbus Memory Center /ID# 245054 Columbus Georgia 31909
QUEST Research Institute /ID# 239459 Farmington Hills Michigan 48334-2977
Advanced Memory Research Institute of NJ /ID# 239533 Toms River New Jersey 08755-5043
Keystone Clinical Studies LLC /ID# 239973 Plymouth Meeting Pennsylvania 19462
Clinical Trials of Texas, Inc /ID# 244917 San Antonio Texas 78229
Re:Cognition Health - Fairfax VA /ID# 239501 Fairfax Virginia 22031-5207

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05291234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05291234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →